{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T20:19:13Z","timestamp":1790194753327,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.seizure.2017.10.018","type":"journal-article","created":{"date-parts":[[2017,10,27]],"date-time":"2017-10-27T15:31:26Z","timestamp":1509118286000},"page":"42-46","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["HLA-A*31:01 and carbamazepine-induced DRESS syndrom in a sample of North African population"],"prefix":"10.1016","volume":"53","author":[{"given":"Kamilia","family":"Ksouda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanen","family":"Affes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nedia","family":"Mahfoudh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lassad","family":"Chtourou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arwa","family":"Kammoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aida","family":"Charfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hend","family":"Chaabane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molka","family":"Medhioub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zouhir","family":"Sahnoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamida","family":"Turki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabil","family":"Tahri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serria","family":"Hammami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled","family":"Zeghal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.seizure.2017.10.018_bib0005","doi-asserted-by":"crossref","first-page":"200","DOI":"10.2340\/00015555-1222","article-title":"Six \u2013year retrospective review of drug reaction with eosinophilia and systemic symptoms","volume":"92","author":"Wongkitisophon","year":"2012","journal-title":"Acta Derm Venereol"},{"issue":"6","key":"10.1016\/j.seizure.2017.10.018_bib0010","first-page":"31","article-title":"Drug reaction with Eosinophilia and systemic symptoms (DRESS) syndrome","volume":"6","author":"Choudary","year":"2013","journal-title":"J Clin Aesthet Dermatol"},{"issue":"6","key":"10.1016\/j.seizure.2017.10.018_bib0015","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S0248-8663(01)00391-5","article-title":"DRESS syndrome \u00e0 la sulfasalazine et \u00e0 la carbamaz\u00e9pine: \u00e0 propos de deux cas","volume":"22","author":"Queyrel","year":"2001","journal-title":"Rev Med Interne"},{"issue":"3","key":"10.1016\/j.seizure.2017.10.018_bib0020","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.reval.2010.01.027","article-title":"Le syndrome d\u2019hypersensibilit\u00e9 (DRESS) n\u2019est qu\u2019une maladie virale","volume":"50","author":"Descamps","year":"2010","journal-title":"Revue Fran\u00e7aise d\u2019allergologie"},{"issue":"12","key":"10.1016\/j.seizure.2017.10.018_bib0025","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.arcped.2007.07.016","article-title":"Le DRESS syndrome, une r\u00e9action d\u2019hypersensibilit\u00e9 aux m\u00e9dicaments qui reste mal connue des p\u00e9diatres","volume":"14","author":"Autret-Leca","year":"2007","journal-title":"Archives de p\u00e9diatrie"},{"issue":"7","key":"10.1016\/j.seizure.2017.10.018_bib0030","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/PEC.0000000000000489","article-title":"Drug reaction with eosinophilia and systemic symptoms syndrome or hematologic malignancy: a case report of a 4-year-old boy","volume":"33","author":"Besli","year":"2017","journal-title":"Pediatr Emerg Care ."},{"key":"10.1016\/j.seizure.2017.10.018_bib0035","doi-asserted-by":"crossref","first-page":"166","DOI":"10.11604\/pamj.2014.19.166.4648","article-title":"DRESS syndrome: \u00e0 propos de trois observations","volume":"19","author":"Chebbi","year":"2014","journal-title":"The Pan African Medical Journal"},{"key":"10.1016\/j.seizure.2017.10.018_bib0040","doi-asserted-by":"crossref","DOI":"10.1111\/bjd.14649","article-title":"Risk assessment of drug-induced DRESS syndrome: a disproportionality analysis using french pharmacovigilance database","author":"Agier","year":"2016","journal-title":"Br J Dermatol"},{"issue":"18","key":"10.1016\/j.seizure.2017.10.018_bib0045","first-page":"9","article-title":"Drug reaction with Eosinophilia and systemic symptoms (DRESS) induced by carbamazepine: a case report and literature review","volume":"2","author":"EL omairi","year":"2014","journal-title":"Afr Med J"},{"issue":"5","key":"10.1016\/j.seizure.2017.10.018_bib0050","first-page":"693","article-title":"Dress syndrome: part I. clinical perspectives","volume":"68","author":"Hussian","year":"2013","journal-title":"Jam Acad Dermatol"},{"issue":"7","key":"10.1016\/j.seizure.2017.10.018_bib0055","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/1346-8138.13430","article-title":"Severe cutaneous adverse drug reactions","volume":"43","author":"Chung","year":"2016","journal-title":"J Dermatol"},{"issue":"4","key":"10.1016\/j.seizure.2017.10.018_bib0060","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/epi.12564","article-title":"Recommendations for HLA-B*15:02 and HLA-A*31:01 genetic testing to reduce the risk of carbamazepine-induced hypersensitivity reactions","volume":"55","author":"Amstutz","year":"2014","journal-title":"Epilepsia"},{"issue":"April (3)","key":"10.1016\/j.seizure.2017.10.018_bib0065","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/ced.12275","article-title":"Presence of the HLA-A*3101 allele in a familial case of drug reaction with eosinophilia and systemic symptoms, secondary to carbamazepine","volume":"39","author":"Anjum","year":"2014","journal-title":"Clin Exp Dermatol"},{"issue":"2","key":"10.1016\/j.seizure.2017.10.018_bib0070","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jaci.2015.06.022","article-title":"New genetic findings lead the way to a better understanding of fundamental mechanisms of drug hypersensitivity","volume":"136","author":"Pirmohamed","year":"2015","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.seizure.2017.10.018_bib0075","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jdermsci.2013.11.013","article-title":"Simple and rapid detection of HLA-A*31:01 for prediction of carbamazepine-induced hypersensitivity using loop-mediated isothermal amplification method","volume":"74","author":"Niihara","year":"2014","journal-title":"J Dermatol Sci"},{"issue":"12","key":"10.1016\/j.seizure.2017.10.018_bib0080","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1056\/NEJMoa1013297","article-title":"HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans","volume":"364","author":"McCormack","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.seizure.2017.10.018_bib0085","first-page":"373","article-title":"M\u00e9thodes d\u2019imputabilit\u00e9 des effets ind\u00e9sirables des m\u00e9dicaments","volume":"33","author":"Dangoumeau","year":"1978","journal-title":"Th\u00e9rapie"},{"key":"10.1016\/j.seizure.2017.10.018_bib0090","first-page":"111","article-title":"Imputabilit\u00e9 des effets inattendus ou toxiques des m\u00e9dicaments","volume":"40","author":"Begaud","year":"1985","journal-title":"Th\u00e9rapie"},{"issue":"3","key":"10.1016\/j.seizure.2017.10.018_bib0095","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1365-2133.2006.07704.x","article-title":"Variability in the clinical pattern of cutaneous Side effects of drugs with systemic symptoms: does a DRESS syndrome really exist?","volume":"156","author":"Kardaun","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.seizure.2017.10.018_bib0100","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3349\/ymj.2007.48.1.11","article-title":"The HLA system: genetics, immunology, clinical testing, and clinical implications","volume":"48","author":"Choo","year":"2007","journal-title":"Yonsei Med J"},{"issue":"3","key":"10.1016\/j.seizure.2017.10.018_bib0105","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1590\/S0365-05962012000300013","article-title":"Drug reaction eosinophilia and systemic symptoms (DRESS)\/drug \u2212induced hypersensitivity syndrome (DIHS): a review of current concept","volume":"87","author":"Criado","year":"2012","journal-title":"An Bras Dermatol."},{"issue":"2","key":"10.1016\/j.seizure.2017.10.018_bib0110","first-page":"118","article-title":"Dress syndrome associated with carbamazepine","volume":"72","author":"Carolina","year":"2015","journal-title":"Bol Med Hosp Infant Mex"},{"issue":"4","key":"10.1016\/j.seizure.2017.10.018_bib0115","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.genhosppsych.2011.04.012","article-title":"Drug reaction with eosinophilia and systemic symptoms induced by carbamazepine: DRESSed to kill","volume":"33","author":"Halink","year":"2011","journal-title":"Gen Hosp Psychiatry"},{"issue":"10","key":"10.1016\/j.seizure.2017.10.018_bib0120","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.neurol.2009.02.009","article-title":"Syndrome d\u2019hypersensibilit\u00e9 aux anti\u00e9pileptiques. Cas particulier de la lamotrigine","volume":"165","author":"Taillia","year":"2009","journal-title":"Rev Neurol (Paris)"},{"issue":"3","key":"10.1016\/j.seizure.2017.10.018_bib0125","first-page":"208","article-title":"Reversal of acute liver faillure with N-acetylcysteine and prednisone in a patient with Dress syndrome: a case report and literature review","volume":"79","author":"P\u00e9rez-Reyes","year":"2014","journal-title":"Rev Gastroenterol Mex"},{"issue":"1","key":"10.1016\/j.seizure.2017.10.018_bib0130","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jemermed.2011.05.052","article-title":"Phenytoin \u2212induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a case report from the emergency department","volume":"44","author":"Oelze","year":"2013","journal-title":"J Emerg Med"},{"issue":"7","key":"10.1016\/j.seizure.2017.10.018_bib0135","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.amjmed.2011.01.017","article-title":"The dress syndrome: a literature review","volume":"124","author":"Cacoub","year":"2011","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.seizure.2017.10.018_bib0140","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.revmed.2014.10.004","volume":"36","author":"Lebrun-Vignes","year":"2014","journal-title":"Toxidermies Rev Med Interne"},{"issue":"9","key":"10.1016\/j.seizure.2017.10.018_bib0145","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1111\/j.1528-1167.2008.01660.x","article-title":"Carbamazepine-induced DRESS and HHV6 primary infection: the importance of skin tests","volume":"49","author":"Aouam","year":"2008","journal-title":"Epilepsia"},{"issue":"5","key":"10.1016\/j.seizure.2017.10.018_bib0150","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.trsl.2012.01.004","article-title":"Genetic and immune predictors for hypersensitivity syndrome to antiepileptic drugs","volume":"159","author":"Neuman","year":"2012","journal-title":"Transl Res"},{"issue":"1","key":"10.1016\/j.seizure.2017.10.018_bib0155","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jbspin.2013.05.002","article-title":"Dress syndrome","volume":"81","author":"Descamps","year":"2014","journal-title":"Joint Bone Spine"},{"issue":"46","key":"10.1016\/j.seizure.2017.10.018_bib0160","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1126\/scitranslmed.3001116","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): a multiorgan antiviral T cell response","volume":"2","author":"Picard","year":"2010","journal-title":"Sci Transl Med"},{"issue":"3","key":"10.1016\/j.seizure.2017.10.018_bib0165","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/bjd.12389","article-title":"HLA-B*58:01 is a risk factor for allopurinol-induced DRESS and Stevens-Johnson syndrome\/toxic epidermal necrolysis in a Portuguese population","volume":"169","author":"Gon\u00e7alo","year":"2013","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.seizure.2017.10.018_bib0170","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.dsi.2013.09.006","article-title":"Drug reaction with eosinophilia and systemic symptoms: a drug-induced hypersensitivity syndrome with variable clinical features","volume":"31","author":"Chen","year":"2013","journal-title":"Dermatologica sinica"},{"issue":"6","key":"10.1016\/j.seizure.2017.10.018_bib0175","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1177\/2042098613499791","article-title":"The risk of cutaneous adverse reactions among patients with the HLA-A*31:01 alleles who are given carbamazepine, oxcarbazepine or eslicarbazepine: a perspective review","volume":"4","author":"Kaniwa","year":"2013","journal-title":"Ther Adv Drug Saf"},{"issue":"4","key":"10.1016\/j.seizure.2017.10.018_bib0180","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/j.1399-0039.2004.00313.x","article-title":"HLA class-I and HLA class-II phenotypic, gene and haplotypic frequencies in Tunisians by using molecular typing data","volume":"64","author":"Ayed","year":"2004","journal-title":"Tissue Antigens"},{"issue":"6","key":"10.1016\/j.seizure.2017.10.018_bib0185","doi-asserted-by":"crossref","first-page":"189","DOI":"10.5698\/1535-7511-11.6.189","article-title":"Carbamazepine hypersensitivity: progress toward predicting the unpredictable","volume":"11","author":"Gidal","year":"2011","journal-title":"Epilepsy Curr"},{"issue":"10","key":"10.1016\/j.seizure.2017.10.018_bib0190","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1346-8138.2008.00548.x","article-title":"Human leucocyte antigen genotypes in carbamazepine-induced severe cutaneous adverse drug response in japonese patients","volume":"35","author":"Kashiwagi","year":"2008","journal-title":"J Dermatol"},{"issue":"2","key":"10.1016\/j.seizure.2017.10.018_bib0195","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jdermsci.2013.10.003","article-title":"Genotype \u2212phenotype association between HLA and carbamazepine \u2212induced hypersensitivity reactions: strength and clinical correlations","volume":"73","author":"Hsiao","year":"2014","journal-title":"J Dermatol Sci"},{"issue":"1\u20132","key":"10.1016\/j.seizure.2017.10.018_bib0200","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.eplepsyres.2011.08.010","article-title":"Carbamazepine-induced severe cutaneous adverse reactions and HLA genotyps in Koreans","volume":"97","author":"Kim","year":"2011","journal-title":"Epilepsy Res"},{"issue":"1","key":"10.1016\/j.seizure.2017.10.018_bib0205","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/clpt.2013.55","article-title":"HLA-A*31:01 and HLA-B*15:02 as genetic markers for carbamazepine hypersensitivity in Children","volume":"94","author":"Amstutz","year":"2013","journal-title":"Clin Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.seizure.2017.10.018_bib0210","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.genhosppsych.2012.08.004","article-title":"Carbamazepine \u2212induced hypersensitivity syndrome in chronic schizophrenia","volume":"35","author":"Pan","year":"2013","journal-title":"Gen Hosp Psychiatry"},{"issue":"2","key":"10.1016\/j.seizure.2017.10.018_bib0215","doi-asserted-by":"crossref","first-page":"68","DOI":"10.5415\/apallergy.2015.5.2.68","article-title":"HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in Vietnamese","volume":"5","author":"Nguyen","year":"2015","journal-title":"Asia Pac Allergy"},{"issue":"6","key":"10.1016\/j.seizure.2017.10.018_bib0220","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.seizure.2011.02.003","article-title":"Association between HLA-B*1502 allele and carbamazepine-induced severe cutaneous adverse reactions in Han people of Southern of Southern China mainland","volume":"20","author":"Wang","year":"2011","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2017.10.018_bib0225","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1111\/j.1528-1167.2007.01022.x","article-title":"Association between HLA-B*1502 allele and antiepileptic drug-induced cutaneous reactions in Han Chinese","volume":"48","author":"Man","year":"2007","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.seizure.2017.10.018_bib0230","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1365-4632.2010.04745.x","article-title":"Association of HLA-B*1502 with carbamazepine-induced toxic epidermal necrolysis and Stevens-Johnson syndrome in Malaysian population","volume":"50","author":"Chang","year":"2011","journal-title":"Int J Dermatol"},{"issue":"12","key":"10.1016\/j.seizure.2017.10.018_bib0235","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1111\/j.1528-1167.2008.01719.x","article-title":"Carbamazepine and phenytoin induced Stevens-Johnson syndrome is associated with HLA-B*1502 allele in Thai population","volume":"49","author":"Locharernkul","year":"2008","journal-title":"Epilepsia"},{"issue":"23","key":"10.1016\/j.seizure.2017.10.018_bib0240","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1212\/WNL.0000000000004008","article-title":"HLA-A*24:02 as a common risk factor for antiepileptic drug-induced cutaneous adverse reactions","volume":"88","author":"Shi","year":"2017","journal-title":"Neurology"}],"container-title":["Seizure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105913111730448X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105913111730448X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T01:50:05Z","timestamp":1761011405000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S105913111730448X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":48,"alternative-id":["S105913111730448X"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2017.10.018","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HLA-A*31:01 and carbamazepine-induced DRESS syndrom in a sample of North African population","name":"articletitle","label":"Article Title"},{"value":"Seizure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2017.10.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 British Epilepsy Association. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}